v3.26.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Stock-based Compensation  
Schedule of stock-based compensation expense

Three Months Ended

March 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Research and development

$

2,302

$

985

General and administrative

 

3,183

 

1,286

$

5,485

$

2,271

Schedule of of stock options activity under the plan

Weighted

Weighted

average

average

remaining

Aggregate

exercise

contractual

Intrinsic Value

  ​ ​ ​

Options

  ​ ​ ​

price

  ​ ​ ​

term (years)

  ​ ​ ​

(in thousands)

Outstanding as of December 31, 2025

 

4,328,880

$

15.56

 

Granted

 

2,950,250

 

22.62

 

 

Exercised

 

(31,195)

 

5.15

 

Forfeited/Expired

(27,351)

9.46

Outstanding as of March 31, 2026

 

7,220,584

18.48

8.68

$

40,051

Exercisable as of March 31, 2026

 

1,986,886

9.95

 

7.09

27,924

Vested and expected to vest at March 31, 2026

 

7,220,584

$

18.48

8.68

$

40,051

Schedule of assumptions used in estimating the fair value of options

Three Months Ended

March 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Risk-free interest rate

 

3.72% - 3.94%

4.02% - 4.37%

Expected term

 

6.1 years

 

6.1 years

Expected volatility

 

87.3%

98.3%

Expected dividend yield

 

 

Estimated fair value of the Company's common stock per share

$

20.80 - 24.31

 

$

22.03 - 27.56